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Abstract
Background: Betaine, beetroot juice, and supplemental nitrate have recently been reported to improve certain
aspects of exercise performance, which may be mechanistically linked to increased nitric oxide. The purpose of the
present study was to investigate the effect of betaine supplementation on plasma nitrate/nitrite, a surrogate
marker or nitric oxide, in exercise-trained men.
Methods: We used three different study designs (acute intake of betaine at 1.25 and 5.00 grams, chronic intake of
betaine at 2.5 grams per day for 14 days, and chronic [6 grams of betaine per day for 7 days] followed by acute
intake [6 grams]), all involving exercise-trained men, to investigate the effects of orally ingested betaine on plasma
nitrate/nitrite. Blood samples were collected before and at 30, 60, 90, and 120 min after ingestion of 1.25 and 5.00
grams of betaine (Study 1); before and after 14 days of betaine supplementation at a dosage of 2.5 grams (Study 2);
and before and after 7 days of betaine supplementation at a dosage of 6 grams, followed by acute ingestion of 6
grams and blood measures at 30 and 60 min post ingestion (Study 3).
Results: In Study 1, nitrate/nitrite was relatively unaffected and no statistically significant interaction (p = 0.99),
dosage (p = 0.69), or time (p = 0.91) effects were noted. Similar findings were noted in Study 2, with no
statistically significant interaction (p = 0.57), condition (p = 0.98), or pre/post intervention (p = 0.17) effects noted
for nitrate/nitrite. In Study 3, no statistically significant changes were noted in nitrate/nitrite between collection
times (p = 0.97).
Conclusion: Our data indicate that acute or chronic ingestion of betaine by healthy, exercise-trained men does
not impact plasma nitrate/nitrite. These findings suggest that other mechanisms aside from increasing circulating
nitric oxide are likely responsible for any performance enhancing effect of betaine supplementation.
Background
Betaine (chemically known as 2-(Trimethylammonio)
ethanoic acid, hydroxide, inner salt) is isolated from
sugar beets and sold for a variety of uses, including ani-
mal feed, as a food ingredient, and as a dietary supple-
ment. Betaine has several noted effects related to human
health and function, including acting as an osmolyte
(protecting cells against dehydration [1]), as an antioxi-
dant agent (protecting cells against free radicals) [2], as a
methyl group donor (lowering potentially harmful levels
of homocysteine [3]), and as a vascular protectant [4].
Although traditionally not used for purposes of exer-
cise performance, over the past few years investigators
have reported positive findings for betaine in this regard.
For example, the powdered form of betaine has been
noted to improve certain aspects of exercise performance
when active college-aged men ingested a dosage of 2.5
grams per day for 14 [5] or 15 days [6]. We have recently
completed a study which corroborates these findings
(unpublished data). Moreover, recent studies using either
beetroot juice (500 mL/day–providing approximately
340 mg of dietary nitrate) [7-9] or sodium nitrate [10]
have noted favorable outcomes pertaining to endurance
exercise performance, while also noting a significant
increase in plasma nitrite levels [7-9].
Although the mechanism for the ergogenic effect of
betaine itself has yet to be elucidated, it has been sug-
gested that improvements in exercise performance follow-
ing nitrate ingestion may be at least partially associated
with the increase in the production/availability of nitric
oxide [7,8]. More recently, it has been noted that nitrate
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healthy human subjects [11], which may provide addi-
tional mechanistic data pertaining to an ergogenic effect.
Nitric oxide, which is synthesized in the body from
L-arginine, oxygen, and a variety of other cofactors by a
family of enzymes known as nitric oxide synthases [12],
was originally referred to as endothelium-derived relaxing
factor [13], due to its ability to promote vasorelaxion of
smooth muscle.
W h i l en i t r i co x i d eh a sn u m e r o u so t h e rf u n c t i o n s
within the human body [14,15], in relation to sport
nutrition and “nitric oxide stimulating dietary supple-
ments”,t h epotential for nitric oxide to promote an
increase in blood flow to the working muscles appears
of most interest. While direct evidence is not available
to support this notion, the widespread theory within the
sport nutrition industry is that an increase in circulating
nitric oxide would lead to an increase in blood flow to
exercising muscle, which in turn would lead to an
increase in nutrient delivery to and waste removal from
that muscle, leading to enhanced exercise performance
and recovery. Of course, this is largely speculation, as
has been discussed in more detail recently [16].
With regards to betaine and the potential for increas-
ing nitric oxide, a study by Iqbal and colleagues found
that daily supplementation at an oral dosage of 6 grams
for 7 days, followed by a single serving on day 8 of
3 grams, had a profound effect (20-90%) on elevating
blood nitrate/nitrite, a surrogate marker of nitric oxide
[17]. Similar results were reported by Iqbal and cowor-
kers in another study [18]. However, aside from these
studies (available only as abstracts and within a US
patent application [US 2007/2013399 A1], and not in
manuscript form), no published investigations have
focused on the effect of betaine to elevate nitrate/nitrite.
Therefore, the purpose of our work was to investigate
the effects of orally ingested betaine in exercise-trained
men (the most likely candidates for use of betaine as an
ergogenic aid) using three different study designs (acute
intake at two different dosages, chronic intake at one
dosage, and chronic followed by acute intake–as to
replicate the work of Iqbal et al.). We hypothesized that
betaine ingestion would increase plasma nitrate/nitrite




Subjects for all three studies were recruited from the
University of Memphis Campus and surrounding com-
munity. Subjects were allowed to participate in more
than one study. However, this was only the case for a
few of the subjects. Study 1 was completed first, fol-
lowed by an approximate one month break before
beginning Study 2. Study 3 was started approximately
five months after the completion of Study 2. Subjects
were not smokers, did not have self-reported cardiovas-
cular or metabolic disease, and were exercise-trained.
Subjects were not using dietary supplements believed
to influence blood nitrate/nitrite. That is, subjects
were allowed to continue their normal intake of multi-
vitamin/mineral supplements, as well as protein powder.
Characteristics of subjects are presented in Table 1.
Health history, drug and dietary supplement usage, and
physical activity questionnaires were completed by sub-
jects to determine eligibility. Subjects were instructed to
maintain their current exercise and dietary intake pro-
grams throughout the study periods. However, in all
three studies subjects were instructed to refrain from
strenuous exercise during the 24 hours prior to each
test session, and to avoid intake of nitrate rich foods
(e.g., cured meats, beets, spinach). All studies were
approved by the university committee for human sub-
ject research (H10-43; H10-44; H11-09) and all subjects
provided written consent.
Screening
For all studies, during the initial visit to the laboratory,
subjects completed the informed consent form, health
and physical activity questionnaires. Subjects’ heart rate
and blood pressure, height, weight, waist and hip cir-
cumference, and skinfold thickness (7 site) was mea-
sured and used for descriptive purposes. Subjects were
provided with food logs and instructions regarding how
to complete these logs during the day prior to each test
day.
Testing
For all studies, subjects reported to the laboratory in the
morning hours (6:00-9:00 am) following a 10 hour over-
night fast. Upon arrival to the lab, subjects rested for
10 minutes. The betaine used in all studies was delivered
in powder form (BetaPower™; 99% pure betaine anhy-
drous; Danisco; Copenhagen, Denmark). Specific proce-
dures for each of the three studies are provided below.
Study 1
Effect of acute ingestion of betaine at two different
dosages on plasma nitrate/nitrite: Subjects reported to
the lab on two different days separated by one week.
During both visits subjects consumed betaine mixed in
240 mL of water at a dosage of either 1.25 or 5.00
grams. The order of the dosing was randomized and
subjects were blind to the dosage. Blood samples were
taken before (after the 10 minute quiet rest period) and
at 30, 60, 90, and 120 minutes following ingestion in
order to determine the effect of a single dosage of
betaine on plasma nitrate/nitrite. No food or calorie
containing beverages were allowed during the test
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matched for each subject during both days of testing.
Study 2
Effect of chronic ingestion of betaine on plasma nitrate/
nitrite: Subjects were randomly assigned in double-blind
manner using a cross-over design to betaine (2.5 grams
of betaine powder mixed into 500 mL of Gatorade
®)o r
placebo (500 mL of Gatorade
®). Subjects were instructed
to consume 250 mL twice per day. Betaine powder is tas-
teless to most individuals when mixed into 500 mL of
Gatorade
®. To better ensure that subjects consumed the
entire dosage of 2.5 grams of betaine each day, without
the need for subjects to mix the betaine into a beverage
themselves, Gatorade
® w a su s e da sad e l i v e r yv e h i c l e –as
the betaine could be added to 500 mL Gatorade
® bottles
by investigators and distributed to subjects for the entire
14 day period. This has been done in prior work with
betaine [5,6]. The treatment period for both conditions
was 14 days and a 21 day washout period was included
between conditions. Blood samples were taken before
and after each 14 day treatment period (after the 10 min-
ute quiet rest period) in order to determine the effect of
chronic supplementation with betaine on plasma nitrate/
nitrite.
Study 3
Effect of chronic followed by acute ingestion of betaine
on plasma nitrate/nitrite: Subjects reported to the labora-
tory on day 1 and day 8. On day 1, subjects simply pro-
vided a fasting, resting blood sample. They were then
provided with individual servings of betaine (3 grams per
serving) and instructed to ingest two servings per day
(6 grams total) for seven days, mixed in water. Subjects
returned to the lab on day 8 and a fasting, resting blood
sample was obtained. Subjects then ingested 6 grams of
betaine mixed into 150 mL of water. Rather than use
Gatorade
®, as was done in Study 2, we chose to use
water only (at a lower volume), in an attempt to more
closely mimic the work of Iqbal and coworkers [17].
Additional blood samples were taken at 30 and 60 min-
utes post ingestion. No food or calorie containing bev-
erages were allowed during the test period, although
water was allowed ad libitum and matched for each sub-
ject during both days of testing. This design allowed us
to determine both the chronic and acute effects of
betaine ingestion of plasma nitrate/nitrite. This third
d e s i g nd i f f e r e df r o md e s i g n s1a n d2i nt h a tw eu s e da
higher dosage of betaine during the chronic supplemen-
tation period, and while the 6 gram acute dosage was not
much different than the 5 gram acute dosage provided in
Study 1, this was preceded by a 7 day treatment period
with 6 grams of betaine per day. In comparison, Study 1
simply used a single ingestion of betaine without any pre-
treatment period. It should be noted that while we
attempted to mimic as closely as possible the design of
Iqbal and colleagues [17], due to the fact that their work
was not presented in peer reviewed manuscript format, it
is possible that some design differences did occur
between our study and their work.
Blood Processing and Biochemistry
At each time of blood collection, venous samples
(~7 mL) were taken from an antecubital vein via needle
and Vacutainer
®. Repeated venipunctures were used for
blood collection in all studies. We have noted in prior
work using resistance trained men as subjects that per-
forming repeated venipunctures is not associated with
problems in obtaining blood samples. Moreover, we
have compared the use of repeated venipunctures with
the use of indwelling catheter placement on serial blood
sample collection over time, and have noted no differ-
ence in terms of endothelial cell derived peptides (e.g.,
endothelin-1 [19]).
Following collection, whole blood samples were placed
immediately in a refrigerated centrifuge and processed
(1500 g for 15 minutes at 4°C) in order to separate the
plasma from cells. Plasma was then stored at -70°C until
analyzed for nitrate/nitrite using a commercially avail-
able colorimetric assay kit (Catalog#: 780001; Caymen
Chemical, Ann Arbor, MI), according to the procedures
provided by the manufacturer. After being thawed,
plasma samples were centrifuged at 10,000 g for 5 min-
utes in a refrigerated centrifuge (4°C). Following the
addition of a nitrate reductase co-factor to each diluted
sample, nitrate reductase was added and the mixture







Age (yrs) 25 ± 6 23 ± 3 27 ± 5
Height (cm) 178 ± 6 178 ± 8 178 ± 3
Weight (kg) 86 ± 15 82 ± 12 81 ± 7
BMI (kg∙m
-2) 2 7±4 2 6±4 2 6±3







Resting heart rate (bpm) 66 ± 5 68 ± 5 62 ± 10
Resting SBP (mmHg) 117 ± 6 114 ± 11 111 ± 11
Resting DBP (mmHg) 74 ± 8 73 ± 9 61 ± 8
Years resistance exercise training 7 ± 8 4 ± 3 7 ± 6
Hours per week resistance
exercise
4±3 4±1 4±1
Years aerobic exercise training 4 ± 4 3 ± 3 5 ± 4
Hours per week aerobic exercise 2 ± 1 2 ± 2 2 ± 1
Data are mean ± SD.
Study 1: cross-over design with subjects consuming either 1.25 or 5.00 grams
of betaine in a single ingestion.
Study 2: cross-over design with subjects consuming 2.5 grams of betaine or a
placebo daily for 14 days; 21 day washout period between each condition.
Study 3: subjects consumed 6 grams of betaine daily for 7 days.
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version of nitrate to nitrite. Greiss reagent was then
added, which converts nitrite into a deep purple azo
compound. The absorbance was then detected at 540
nm using a PowerWave microplate spectrophotometer
(BioTek Instruments, Winooski, VT). Quantification was
performed with a calibration curve. The coefficient of
variation for this assay in our laboratory is <8%. The
detection limit, as per the manufacturer, is ≥2.5 μM. It
should be noted that the products of nitric oxide meta-
bolism, nitrate (NO3
-)a n dn i t r i t e( N O 2
-), are typically
measured in blood samples due to the short half life of
nitric oxide (i.e., equal to only 3-4 seconds). For Study
3, in addition to total nitrate/nitrite, nitrite only was
measured using the same procedures outlined above,
with the exclusion of nitrate reductase co-factor and
nitrate reductase. The measurement of nitrite was done
as an afterthought following the analysis of nitrate/
nitrite. Our rationale for including the sole measure of
nitrite in Study 3 was based on recent findings for
beetroot juice and nitrite elevation [7-9]. We believed
that of all three studies presented within, the dosage
and duration of treatment of betaine used in Study 3
would yield the best possibility for an increase in
nitrite to be noted. If significantly elevated, we may
have then had rationale to measure nitrite in samples
obtained in Studies 1 and 2. However, this was not the
case.
Physical Activity and Dietary Intake
Subjects were asked to refrain from strenuous physical
activity during the 24 hours before test days. Subjects
were asked to record all food and drink consumed dur-
ing the day prior to each test day. Upon receipt of the
first diet record, subjects received a copy and were
asked to duplicate this intake during the day immedi-
ately prior to the subsequent test day. All records were
analyzed for total kilocalories, protein, carbohydrate, fat,
vitamin C, and vitamin E (Food Processor SQL, version
9.9, ESHA Research, Salem, OR).
Statistical Analysis
F o rS t u d y1 ,d a t aw e r ea n a l y z e du s i n ga2( d o s a g e )×5
(time) analysis of variance (ANOVA). For Study 2, data
were analyzed using a 2 (condition) × 2 (pre/post inter-
vention) ANOVA. For Study 3, data were analyzed using
one way ANOVA with time as the factor of interest. Data
for all studies are presented as mean ± standard error of
the mean. Subject descriptive characteristics are pre-
sented as mean ± standard deviation. All analyses were
performed using JMP statistical software (version 4.0.3,
SAS Institute, Cary, NC). Statistical significance was set
at P ≤ 0.05.
Results
Subject descriptive characteristics are presented in Table 1.
Dietary data are presented in Table 2, Table 3, and Table 4.
No statistically significant differences were noted in any
dietary variable in any of the studies (p > 0.05). Results for
nitrate/nitrite are presented in Table 5 (Study 1), Table 6
(Study 2), and Table 7 (Study 3). In Study 1, no statistically
significant interaction (p = 0.99), dosage (p = 0.69), or time
(p = 0.91) effects were noted. In Study 2, no statistically sig-
nificant interaction (p = 0.57), condition (p = 0.98), or pre/
post intervention (p = 0.17) effects were noted. In Study 3,
no statistically significant differences were noted in nitrate/
nitrite (p = 0.97) or nitrite (p = 0.97) between collection
times.
Discussion
When collectively considering data obtained from the
three separate studies, we report that acute or chronic
ingestion of betaine does noti m p a c tp l a s m an i t r a t e /
nitrite in exercise-trained men. These findings contra-
dict those of Iqbal and coworkers [17,18], and suggest
that other mechanisms aside from increasing circulating
nitric oxide are likely responsible for the reported ergo-
genic benefit of betaine supplementation that has been
reported by others [5,6]. Of course, our omission of
exercise performance measures within the present
manuscript may be considered a limitation of this work.
When considering the findings presented here along
with those of Iqbal and colleagues [17,18], it is possible
that differences in the subject sample may be responsi-
ble for the differing results. Specifically, our subjects
were young, healthy, exercise-trained men, while those
in the Iqbal work were simply reported to be “healthy
volunteers”. Further work is needed to replicate the
findings of Iqbal and colleagues [17,18] in middle and
older age adults, to determine if individuals other than
healthy, exercise-trained men benefit from betaine sup-
plementation in terms of elevating circulation nitrate/
nitrite.
Table 2 Dietary data for subjects in Study 1 during the
day prior to each test day
Variable Betaine 1.25 g Betaine 5.00 g
Kilocalories 2079 ± 295 1812 ± 491
Protein (g) 73 ± 6 71 ± 11
Carbohydrate (g) 277 ± 46 256 ± 71
Fat (g) 79 ± 11 61 ± 19
Vitamin C (mg) 101 ± 28 86 ± 73
Vitamin E (mg) 13 ± 11 15 ± 12
Data are mean ± SEM.
No statistically significant differences noted in any dietary variable (p > 0.05).
Study involved a cross-over design with subjects consuming either 1.25 or
5.00 grams of betaine in a single ingestion.
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individuals may exhibit diminished ability to generate
nitric oxide [20,21], which ultimately may result in
impaired blood flow [20]. Such findings may have impli-
cations in relation to betaine supplementation across
different populations. That is, perhaps older individuals
with lower basal nitrate/nitrite levels may respond more
favorably to betaine supplementation as compared to
young and healthy subjects. To our knowledge, no study
has yet determined this. However, at least one study has
compared plasma betaine levels between younger and
older subjects, noting higher levels for older compared
to younger subjects [22]. It is presently unknown what
the physiological relevance of this difference is in terms
of how an individual might respond to betaine supple-
mentation for purposes of increasing circulating nitrate/
nitrite. Of course, betaine supplementation may provide
health benefits in areas outside of plasma nitrate/nitrite
(e.g, reducing homocysteine, reducing the risk of cardio-
vascular disease and metabolic syndrome) [1], which
may warrant its use by a wide variety of individuals–
both older and younger. More work is needed to
determine the potential health related benefits of betaine
supplementation in human subjects.
Dietary supplements that are purported to increase
circulating nitric oxide have received a great deal of
attention in recent years [16]. The effect that appears to
be of greatest interest is that of increasing blood flow to
exercising skeletal muscle, as well as regulating muscle
tissue atrophy and hypertrophy. Advertisements sup-
porting most such products suggest that an increase in
blood flow will result in increased oxygen and nutrient
delivery (e.g., amino acids, fatty acids, glucose) to skele-
tal muscle during exercise. This would then enhance
exercise performance, while the increased blood flow
will be retained during the post-exercise period, allowing
for enhanced exercise recovery–which would ultimately
result in muscle hypertrophy. While these hypotheses
are interesting, there exists no evidence that such events
take place, at least as applied to human subjects con-
suming oral dietary supplements purported to increase
nitric oxide. Even for dietary ingredients reported to
result in measurable increases in plasma nitrate/nitrite,
such as glycine propionyl-L-carnitine [23,24], additional
studies which include functional, rather than just bio-
chemical outcomes, are needed. Without such studies,
there is no way of knowing what, if any, physiological
effect an increase in circulating nitrate/nitrite has within
an in vivo system.
Aside from nutritional supplements, other lifestyle
methods are available for increasing nitric oxide, includ-
ing regular exercise training [25,26] and modification of
dietary intake to include more fruits, vegetables, and
Table 4 Dietary data for subjects in Study 3 during the
day prior to each test day
Variable Pre Post
Kilocalories 2264 ± 196 2043 ± 236
Protein (g) 146 ± 19 140 ± 20
Carbohydrate (g) 248 ± 42 249 ± 52
Fat (g) 82 ± 8 61 ± 6
Vitamin C (mg) 89 ± 30 82 ± 24
Vitamin E (mg) 7 ± 2 6 ± 2
Data are mean ± SEM.
No statistically significant differences noted in any dietary variable (p > 0.05).
Study involved subjects consuming 6 grams of betaine daily for 7 days.
Table 5 Plasma nitrate/nitrite (μmol∙L
-1) for subjects in
Study 1
Dosage Pre 30 min 60 min 90 min 120 min
1.25 g 34.6 ± 6.9 32.1 ± 7.2 31.8 ± 5.7 28.2 ± 4.6 27.9 ± 5.0
5.00 g 32.9 ± 8.4 29.1 ± 6.9 28.4 ± 8.0 27.3 ± 8.0 28.2 ± 7.4
Data are mean ± SEM.
No statistically significant interaction (p = 0.99), dosage (p = 0.69), or time
(p = 0.91) effects noted.
Study involved a cross-over design with subjects consuming either 1.25 or
5.00 grams of betaine in a single ingestion; blood samples collected Pre, 30,
60, 90, and 120 min post intake.
Table 6 Plasma nitrate/nitrite (μmol∙L
-1) for subjects in
Study 2
Condition Pre Intervention Post Intervention
Placebo 24.3 ± 4.8 17.5 ± 2.4
Betaine 22.4 ± 3.4 19.6 ± 3.1
Data are mean ± SEM.
No statistically significant interaction (p = 0.57), condition (p = 0.98), or pre/
post intervention (p = 0.17) effects noted.
Study involved a cross-over design with subjects consuming 2.5 grams of
betaine or a placebo daily for 14 days; 21 day washout period between each
condition; blood samples collected before (Pre Intervention) and after (Post
Intervention) each 14 day period.
Table 3 Dietary data for subjects in Study 2 during the









Kilocalories 1931 ± 183 2147 ± 265 2242 ± 288 2551 ± 325
Protein (g) 115 ± 16 122 ± 16 125 ± 24 138 ± 22
Carbohydrate (g) 249 ± 24 267 ± 41 280 ± 41 320 ± 52
Fat (g) 58 ± 8 69 ± 12 73 ± 12 83 ± 11
Vitamin C (mg) 58 ± 18 76 ± 26 102 ± 34 80 ± 16
Vitamin E (mg) 5 ± 2 4 ± 1 3 ± 1 4 ± 2
Data are mean ± SEM.
No statistically significant condition × pre/post intervention interaction, pre/
post intervention, or condition main effects noted for kilocalories (p = 0.69;
p = 0.46; p = 0.13), protein (p = 0.94; p = 0.61; p = 0.57), carbohydrate (p =
0.56; p = 0.67; p = 0.17), fat (p = 0.90; p = 0.41; p = 0.14), vitamin C (p = 0.43;
p = 0.92; p = 0.33), or vitamin E (p = 0.41; p = 0.86; p = 0.82), respectively.
Study involved a cross-over design with subjects consuming 2.5 grams of
betaine or a placebo daily for 14 days; 21 day washout period between each
condition.
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Canale RE, Farney TM: A 21 day Daniel Fast improves
selected biomarkers of antioxidant status and oxidative
stress in men and women. Nutrition and Metabolism.I n
Press]. Considering the multiple health benefits asso-
ciated with these activities, if elevating circulating nitric
oxide is a goal, it may be best to simply focus on these
activities.
Conclusion
Acute or chronic ingestion of betaine by healthy, exer-
cise-trained men does not impact plasma nitrate/nitrite.
It is possible that betaine supplementation by older and/
or deconditioned individual s ,o rp o s s i b l yb yw o m e n ,
may result in elevated nitrate/nitrite levels in plasma.
Additional work is needed to confirm such a hypothesis.
Based on our findings, in regards to the recently
reported ergogenic properties of betaine [5,6], mechan-
isms aside from an elevation in nitrate/nitrite are likely
responsible for these effects.
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